体液微小RNA在胆管癌诊断中的研究进展

摘要/Abstract

摘要：胆管癌发展慢但转移性极高，被发现时往往已错过最佳手术期，目前缺乏有效的诊断指标。近年来，随着分子生物学的飞速发展，研究发现微小RNA与胆管癌关系密切。由于微小RNA在各种类型的体液中有很大的稳定性，所以血清/血浆及胆汁中的微小RNA均有望成为胆管癌诊断中的潜在生物标志物。

邹荣基,马庆久. 体液微小RNA在胆管癌诊断中的研究进展[J]. 国际肿瘤学杂志, 2017, 44(4): 300-303.

Zou Rongji, Ma Qingjiu. Research progress on body fluids microRNAs in the diagnosis of cholangiocarcinoma[J]. Journal of International Oncology, 2017, 44(4): 300-303.

［1］刘子沛, 郑燕华, 白洁, 等. 多种肿瘤标志物检测在胆管癌诊断中的临床意义［J］. 中华肝胆外科杂志, 2013, 19(9): 657-660. DOI: 10.3760/cma.j.issn.10078118.2013.09.005. ［2］ Hwang J, Kim YK, Park MJ, et al. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI［J］. J Magn Reson Imaging, 2012, 36(4): 881-889. DOI: 10.1002/jmri.23728. ［3］ Motawi TK, Rizk SM, Ibrahim TM, et al. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis［J］. Cell Biochem Funct, 2016, 34(3): 142-148. DOI: 10.1002/cbf.3171. ［4］ Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer［J］. Theranostics, 2015, 5(10): 1122-1143. DOI: 10.7150/thno.11543. ［5］ Braicu C, Cojocneanu-Petric R, Chira S, et al. Clinical and pathological implications of miRNA in bladder cancer［J］. Int J Nanomedicine, 2015, 10: 791-800. DOI: 10.2147/IJN.S72904. ［6］ Fujita Y, Kuwano K, Ochiya T, et al. The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer research［J］. Biomed Res Int, 2014, 2014: 486413. DOI: 10.1155/2014/486413. ［7］ Li L, Masica D, Ishida M, et al. Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis［J］. Hepatology, 2014, 60(3): 896-907. DOI: 10.1002/hep.27050. ［8］ Plieskatt J, Rinaldi G, Feng Y, et al. A microRNA profile associated with opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma［J］. BMC Cancer, 2015, 15: 309. DOI: 10.1186/s12885-015-1270-5. ［9］ Liang Z, Liu X, Zhang Q, et al. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma［J］. Dig Liver Dis, 2016, 48(10): 1227-1232. DOI: 10.1016/j.dld.2016.07.006. ［10］ Meng F, Henson R, Lang M, et al. Involvement of human microRNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines［J］. Gastroenterology, 2006, 130(7): 2113-2129. DOI: 10.1053/j.gastro.2006.02.057. ［11］ Silakit R, Loilome W, Yongvanit P, et al. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator［J］. J Hepatobiliary Pancreat Sci, 2014, 21(12): 864-872. DOI: 10.1002/jhbp.145. ［12］彭丰, 王敏, 江建新, 等. 微RNA-200b在胆管癌中的表达及其对癌细胞凋亡与侵袭转移特性的影响［J］. 中华肝胆外科杂志, 2014, 20(2): 123-127. DOI: 10.3760/cma.j.issn.1007-8118.2014.02.012. ［13］ Huang M, Wu X, Cao H, et al. Regulatory role of serum miR-224 in invasiveness and metastasis of cholangiocarcinoma［J］. Zhonghua Gan Zang Bing Za Zhi, 2015, 23(10): 748-753. DOI: 10.3760/cma.j.issn.1007-3418.2015.10.008. ［14］ Kojima M, Sudo H, Kawauchi J, et al. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers［J］. PLoS One, 2015, 10(2): e0118220. DOI: 10.1371/journal.pone.0118220. ［15］ Cheng Q, Feng F, Zhu L, et al. Circulating miR-106a is a novel prognostic and lymph node metastasis indicator for cholangiocarcinoma［J］. Sci Rep, 2015, 5: 16103. DOI: 10.1038/srep16103. ［16］ Razumilava N, Gores GJ. Cholangiocarcinoma［J］. Lancet, 2014, 383(9935): 2168-2179. DOI: 10.1016/S0140-6736(13)61903-0. ［17］ Wang S, Yin J, Li T, et al. Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma［J］. Oncol Rep, 2015, 33(2): 819-825. DOI: 10.3892/or.2014.3641. ［18］ Huang S, Chen Y, Wu W, et al. miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor［J］. PLoS One, 2013, 8(12): e80707. DOI: 10.1371/journal.pone.0080707. ［19］ míd D, Kubaková D, Dole-al J, et al. Predictive and prognostic factors of gastric cancer［J］. Rozhl Chir, 2016, 95(4): 156-161. ［20］ Feng J, Yang Y, Zhang P, et al. miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb［J］. J Cell Mol Med, 2014, 18(10): 2125-2134. DOI: 10.1111/jcmm.12398. ［21］ Qu Y, Pan S, Kang M, et al. MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1［J］. Tumour Biol, 2016, 37(4): 5275-5284. DOI: 10.1007/s13277-015-4389-8. ［22］ Huang Y, Yang YB, Zhang XH, et al. MicroRNA-21 gene and cancer［J］. Med Oncol, 2013, 30(1): 376. DOI: 10.1007/s12032-012-0376-8. ［23］ Kishimoto T, Eguchi H, Nagano H, et al. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer［J］. Cancer Sci, 2013, 104(12): 1626-1631. DOI: 10.1111/cas.12300. ［24］ Correa-Gallego C, Maddalo D, Doussot A, et al. Circulating plasma levels of microRNA-21 and microRNA-221 are potential diagnostic markers for primary intrahepatic cholangiocarcinoma［J］. PLoS One, 11(9): e0163699. DOI: 10.1371/journal.pone.0163699. ［25］ Pasternak A, Szura M, Gil K, et al. Metabolism of bile with respect to etiology of gallstone disease-systematic review［J］. Folia Med Cracov, 2014, 54(2): 5-16. ［26］ Munoz-Garrido P, García-Fernández de Barrena M, Hijona E, et al. MicroRNAs in biliary diseases［J］. World J Gastroenterol, 2012, 18(43): 6189-6196. DOI: 10.3748/wjg.v18.i43.6189. ［27］ Haga H, Yan I, Takahashi K, et al. Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma［J］. Gene Expr, 2014, 16(2): 93-99. DOI: 10.3727/105221614X13919976902174. ［28］ Shigehara K, Yokomuro S, Ishibashi O, et al. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer［J］. PLoS One, 2011, 6(8): e23584. DOI: 10.1371/journal.pone.0023584. ［29］ Voigtl-nder T, Gupta SK, Thum S, et al. MicroRNAs in serum and bile of patients with primary sclerosing cholangitis and/or cholangiocarcinoma［J］. PLoS One, 2015, 10(10): e0139305. DOI: 10.1371/journal.pone.0139305. ［30］ Bernuzzi F, Marabita F, Lleo A, et al. Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma［J］. Clin Exp Immunol, 2016, 185(1): 61-71. DOI: 10.1111/cei.12776. ［31］ Shen J, Stass SA, Jiang F. MicroRNAs as potential biomarkers in human solid tumors［J］. Cancer Lett, 2013, 329(2): 125-136. DOI: 10.1016/j.canlet.2012.11.001. ［32］ Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review［J］. EMBO Mol Med, 2012, 4(3): 143159. DOI: 10.1002/emmm.201100209. ［33］ YáezMó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions［J］. J Extracell Vesicles, 2015, 4: 27066. DOI: 10.3402/jev.v4.27066.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[3]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[4]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.
[5]	陈琦, 徐晨阳, 王寅, 雷大鹏.高光谱成像在头颈部肿瘤诊疗中的应用现状[J]. 国际肿瘤学杂志, 2024, 51(5): 298-302.
[6]	张栋岩, 王品, 魏秋亚, 邓成伍, 魏相相, 高远飞, 王琛.索凡替尼靶向联合卡培他滨和奥沙利铂治疗肝内胆管癌术后患者1例及文献复习[J]. 国际肿瘤学杂志, 2024, 51(4): 249-253.
[7]	张丽丽, 谭茹, 房雪利, 杨宇, 桑铮, 李宝生.乳腺导管原位癌影像学诊断、病理学升级及影像学技术进展[J]. 国际肿瘤学杂志, 2024, 51(3): 166-169.
[8]	彭琴, 蔡玉婷, 王伟.KPNA2在肝癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 181-185.
[9]	龚艳, 陈洪雷.微RNA调控卵巢癌顺铂耐药的机制研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 186-190.
[10]	李丹, 李睿尧, 李膺函, 于秀艳, 吴雪峰.血清miR-19b、miR-744-5p水平在非小细胞肺癌诊断中的临床价值[J]. 国际肿瘤学杂志, 2024, 51(2): 83-88.
[11]	金旭东, 陈忠坚, 毛伟敏.MTAP基因在恶性间皮瘤中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 99-104.
[12]	黄镇, 陈永顺.循环肿瘤DNA在肝细胞癌诊疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(1): 59-64.
[13]	王景, 许文婷.中性粒细胞与淋巴细胞比值、癌胚抗原联合凝血指标对直径≤1.0 cm的良恶性乳腺结节鉴别诊断价值研究[J]. 国际肿瘤学杂志, 2023, 50(9): 520-526.
[14]	黄辉, 丁江华.靶向FGFR2治疗晚期胆管癌的研究进展[J]. 国际肿瘤学杂志, 2023, 50(9): 569-573.
[15]	鞠逸凡, 徐晨阳, 雷大鹏.病理组学在头颈部肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(5): 294-298.

体液微小RNA在胆管癌诊断中的研究进展

Research progress on body fluids microRNAs in the diagnosis of cholangiocarcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价